Sherveen S Salek1, Archana Pradeep2, Catherine Guly2, Athimalaipet V Ramanan3, James T Rosenbaum4. 1. Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon. 2. University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom. 3. University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom; School of Clinical Sciences, University of Bristol, Bristol, United Kingdom. 4. Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon; Department of Medicine, Oregon Health & Science University, Portland, Oregon; Legacy Devers Eye Institute, Portland, Oregon. Electronic address: rosenbaj@ohsu.edu.
Abstract
PURPOSE: To describe the phenotype of the uveitis that accompanies juvenile psoriatic arthritis or psoriasis. DESIGN: Observational case series. METHODS: Setting: Two university-based referral clinics: 1 in England, 1 in the United States. STUDY POPULATION: Five children with uveitis and psoriatic arthritis and 1 with uveitis and psoriasis Observational Procedure: Retrospective chart review. MAIN OUTCOME MEASURES: Demographics of subjects such as age and sex; description of ocular and joint disease; surgical and other complications; medical treatment. RESULTS: Five of the 6 children in this series had the onset of disease at or before age 6 (P = .0008 compared to expected age of onset for psoriatic arthritis in childhood). All children in this series had an inadequate response to topical corticosteroids. Most of the children were treated with systemic corticosteroids for many months, yet all of them went on to require methotrexate. Therapy with systemic methotrexate did not suffice, as all the patients also required some form of biologic therapy. Five of 6 had surgeries such as vitrectomy, cataract extraction, or a procedure for glaucoma control. CONCLUSIONS: The observations suggest that the uveitis that accompanies juvenile psoriatic arthritis might be a distinct disease that is particularly severe when its onset affects children aged 6 years or younger.
PURPOSE: To describe the phenotype of the uveitis that accompanies juvenile psoriatic arthritis or psoriasis. DESIGN: Observational case series. METHODS: Setting: Two university-based referral clinics: 1 in England, 1 in the United States. STUDY POPULATION: Five children with uveitis and psoriatic arthritis and 1 with uveitis and psoriasis Observational Procedure: Retrospective chart review. MAIN OUTCOME MEASURES: Demographics of subjects such as age and sex; description of ocular and joint disease; surgical and other complications; medical treatment. RESULTS: Five of the 6 children in this series had the onset of disease at or before age 6 (P = .0008 compared to expected age of onset for psoriatic arthritis in childhood). All children in this series had an inadequate response to topical corticosteroids. Most of the children were treated with systemic corticosteroids for many months, yet all of them went on to require methotrexate. Therapy with systemic methotrexate did not suffice, as all the patients also required some form of biologic therapy. Five of 6 had surgeries such as vitrectomy, cataract extraction, or a procedure for glaucoma control. CONCLUSIONS: The observations suggest that the uveitis that accompanies juvenile psoriatic arthritis might be a distinct disease that is particularly severe when its onset affects children aged 6 years or younger.
Authors: Percival D Sampaio-Barros; Roseneide A Conde; Rubens Bonfiglioli; Manoel B Bértolo; Adil M Samara Journal: Rheumatol Int Date: 2006-09-07 Impact factor: 2.631
Authors: Niccolò Castellino; Antonio Longo; Matteo Fallico; Andrea Russo; Vincenza Bonfiglio; Gilda Cennamo; Federica Fossataro; Gabriella Fabbrocini; Anna Balato; Guglielmo Parisi; Rosa Maria D'urso; Francesco Lacarrubba; Maria Letizia Musumeci; Pietro Alosi; Francesco Petrillo; Giuseppe Micali; Teresio Avitabile; Michele Reibaldi Journal: Front Neurosci Date: 2021-01-25 Impact factor: 4.677
Authors: Christian Nieves-Ríos; Guillermo A Requejo Figueroa; Sofía C Ayala Rodríguez; Alejandra Santiago-Díaz; Eduardo J Rodriguez-Garcia; Alejandro L Perez; Erick Rivera-Grana; Adriana C Figueroa-Díaz; Rafael Martín-García; Armando L Oliver Journal: Case Rep Ophthalmol Med Date: 2022-10-07